Monday 26 October 2015
Valeant Plans To Dispute Negative Report As Woes Drag Down Pharma Market
Valeant Pharmaceuticals will hold a press conference Monday to "lay out the facts" regarding a report that criticized the company's business practices. Secondary loan prices and stocks for drug and biotechnology companies have also been impacted by the spotlight on Valeant.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment